1-3 of 3
Donald L. Siegel
Close
Sort by
Journal Articles

Prognostic Value of FDG-PET in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Jakub Svoboda, Rebecca Elstrom, Elise A. Chong, Charalambos Andreadis, Arnold Berkowitz, Selina M. Luger, David L. Porter, Sunita Nasta, Lisa H. Downs, Donald L. Siegel, Eli Glatstein, Abass Alavi, Edward A. Stadtmauer, Stephen J. Schuster
Journal: Blood
Blood (2005) 106 (11): 2090.
https://doi.org/10.1182/blood.V106.11.2090.2090
Published: 2005
Journal Articles

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy for Relapsed Multiple Myeloma.

Rebecca L. Olin, MD, David L. Porter, MD, Selina M. Luger, MD, Stephen J. Schuster, MD, Donald Tsai, MD, PhD, Sunita Nasta, MD, Alexander Perl, MD, Alison W. Loren, MD, Steven Goldstein, MD, Eli Glatstein, MD, Donald L. Siegel, MD, PhD, Dan T. Vogl, MD, Patricia Mangan, CRNP, Kathleen Cunningham, RN, BSN, Edward A. Stadtmauer, MD
Journal: Blood
Blood (2005) 106 (11): 1170.
https://doi.org/10.1182/blood.V106.11.1170.1170
Published: 2005
Journal Articles

Thalidomide and Dexamethasone Induction Therapy Is Associated with Superior Progression-Free Survival after Autotransplant for Myeloma.

Dan T. Vogl, MD, Selina Luger, MD, David L. Porter, MD, Elise A. Chong, Stephen J. Schuster, MD, Donald E. Tsai, MD, Alexander Perl, MD, Alison W. Loren, MD, MS, Stephen Goldstein, MD, Sunita D. Nasta, MD, Charalambos Andreadis, MD, Patricia A. Mangan, Kimberly Hummel, Donald L. Siegel, MD, PhD, Eli Glatstein, MD, Edward A. Stadtmauer, MD
Journal: Blood
Blood (2005) 106 (11): 1171.
https://doi.org/10.1182/blood.V106.11.1171.1171
Published: 2005